Header Ads

Debate on Hydroxychloroquine’s efficacy: Why we need to be careful about research papers

Debate on Hydroxychloroquine’s efficacy: Why we need to be careful about research papers The retraction of the Lancet study and the restart of HCQ trial by WHO do not mean that the debate on HCQ#39;s efficacy is settled

from Moneycontrol Business News https://www.moneycontrol.com/news/business/debatehydroxychloroquine’s-efficacy-why-we-need-to-be-careful-about-research-papers_13871081.html

No comments:

Powered by Blogger.